
|Articles|February 6, 2020
PPD Goes Public
Advertisement
	Last month, PPD announced its plans to go public-the second time in its existence-filing its IPO for stock in January. Today, it began trading as PPD at $27 a share on the NASDAQ. PPD was founded in 1985 by Fred Eshelman, who took the company public in 1996. In 2011, it went private again with its 
	For more information, click 
Newsletter
Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.
Advertisement
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
ACT Brief: AI, Equity, and Innovation Drive Clinical Research Forward
2
Reducing Site Burden Through Better Technology Integration in Clinical Trials
3
MATTERHORN Trial Findings Signal Paradigm Shift in Early Gastric Cancer Care
4
ACT Brief: AI Partnerships, Data-Driven Site Activation, and FDA Approval for Omvoh’s Single-Injection Regimen
5






.png)



.png)



.png)
.png)
